3-Hydroxy-2-(5-hydroxypentyl)-4H-chromen-4-one: A bidentate or tridentate iron(III) ligand?

Journal of Medicinal Chemistry

Volumn 49, Issue 10, 2006, Pages 3028-3031

  Kong, Xiaole ^a   Zhou, Tao ^a   Neubert, Hendrik ^a   Liu, Zudong ^a   Hider, Robert C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 2 (5 HYDROXYPENTYL) 4H CHROMEN 4 ONE; IRON; LIGAND; UNCLASSIFIED DRUG;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; DRUG DETERMINATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENTROPY; IRON OVERLOAD; NONHUMAN; PKA; RECEPTOR AFFINITY; SPECTROPHOTOMETRY;

CHROMONES; ELECTRON SPIN RESONANCE SPECTROSCOPY; FERRIC COMPOUNDS; HYDROGEN-ION CONCENTRATION; IRON CHELATING AGENTS; LIGANDS; METHANOL; SOLUTIONS; SPECTROPHOTOMETRY; WATER;

EID: 33646716324     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050905t     Document Type: Article

References (13)

1. Barman Balfour, J. A.; Foster, R. H. Deferiprone: a review of its clinical potential in iron overload in β-thalassaemia major and other transfusion-dependent diseases. Drugs 1999, 58, 553-78.
2. Levin, V. A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 1980, 23, 682-4.
3. Lovejoy, D. B.; Richardson, D. R. Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelators. Curr. Med. Chem. 2003, 10, 1035-49.
4. Kicic, A.; Chua, A. C.; Baker, E. The desferrithiocin (DFT) class of iron chelators: potential as antineoplastic agents. Anticancer Drug Des. 2001, 16, 195-207.
5. Cappellini, M. D. Iron-chelating therapy with the new oral agent ICL670 (Exjade). Best Pract. Res. Clin. Haematol. 2005, 18, 289-98.
6. Hancock, R. D.; Martell, A. E. Ligand design for selective complexation of metal ions in aqueous solution. Chem. Rev. 1989, 89, 1875-1914.
7. Merkofer, M. K. R.; Hider, R. C.; Koppenol, W. H. Redox Properties of the Iron Complexes of CP20, CP502, CP 509 and ICL670. Helv. Chim. Acta 2004, 87, 3021-3034.
8. Moridani, M. Y.; Tilbrook, G. S.; Khodr, H. H.; Hider, R. C., Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators. J. Pharm. Pharmacol. 2002, 54, 349-64.
9. Ferrali, M.; Bambagioni, S.; Ceccanti, A.; Donati, D.; Giorgi, G.; Fontani, M.; Laschi, F.; Zanello, P.; Casolaro, M.; Pietrangelo, A. Design, synthesis, and physicochemical and biological characterization of a new iron chelator of the family of hydroxychromenes. J. Med. Chem. 2002, 45, 5776-85.
10. Alderighi, L.; Gans, P.; Ienco, A.; Peters, D.; Sabatini, A.; Vacca, A. Hyperquad simulation and speciation (hyss): a utility program for the investigation of equilibria involving soluble and partially soluble species. Coord. Chem. Rev. 1999, 184, 311-318.
11. Motekaitis, R. J.; Martell, A. E. Stabilities of the iron(III) chelates of 1,2-dimethyl-3-hydroxy-4-pyridinone and related ligands. Inorg. Chim. Acta 1991, 183, 71-80.
12. Gans, P.; Sabatini, A.; Vacca, A. Determination of equilibrium constants from spectrophotometric data obtained from solutions of known pH: the program pHab. Ann. Chim. 1999, 89, 45-49.
13. Gans, P.; O'Sullivan, B. GLEE, A new computer program for glass electrode calibration. Talanta 2000, 51, 33-37.